Table 2.

Correlations between provider-level COVID-19 burden and i) total number of treatments, and ii) percentage treated within 62 days of suspected cancer referral, for breast, lower gastrointestinal, lung, skin, urological, or other cancers for both Wave 1 and Wave 2 of the COVID-19 epidemic in England.

	Total number treated			Proportion treated within 62-day CWT target
	NHS hospital trusts (n)	r	p-value	NHS hospital trusts (n)	r	p-value
Wave 1
Breast
	115	−0.25	<0.01	115	0.03	0.78
Lower GI
	117	−0.25	<0.01	117	−0.11	0.22
Lung
	116	−0.32	0.001	116	−0.09	0.36
Skin
	110	−0.43	<0.001	110	−0.17	0.08
Urological
	120	−0.29	0.001	120	−0.09	0.34
Other tumour sites
	120	−0.22	0.02	120	−0.17	0.06
Wave 2
Breast
	117	0.01	0.98	117	0.08	0.38
Lower GI
	120	−0.13	0.17	120	−0.13	0.15
Lung
	116	−0.05	0.57	116	0.06	0.55
Skin
	113	−0.19	0.05	113	0.05	0.59
Urological
	118	−0.07	0.43	118	−0.10	0.27
Other tumour sites
	120	−0.11	0.23	120	−0.25	<0.01

NHS, National Health System; CWT, Cancer Waiting Time; GI, gastrointestinal.